| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |